AstraZeneca Right of Reference. ▇▇▇▇▇▇▇▇▇ hereby grants to AstraZeneca and its Sublicensees a Right of Reference to all data included in the Regulatory Submissions and Regulatory Approvals Controlled by ▇▇▇▇▇▇▇▇▇ and its Affiliates relating to a Collaboration Compound or Collaboration Products to the extent necessary to obtain Regulatory Approval of any Collaboration Product in the Field in any country of the ROW Territory, and [**] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. ▇▇▇▇▇▇▇▇▇ shall provide a signed statement to this effect, if requested by AstraZeneca, in accordance with 21 C.F.R. § 314.50(g)(3) (or any analogous Applicable Law recognized outside of the United States).
Appears in 2 contracts
Sources: License and Collaboration Agreement (Hutchison China MediTech LTD), License and Collaboration Agreement (Hutchison China MediTech LTD)